Cargando…

β-Cell Function Improvements in Grade I/II Obese Subjects With Type 2 Diabetes 1 Month After Biliopancreatic Diversion: Results from modeling analyses of oral glucose tolerance tests and hyperglycemic clamp studies

OBJECTIVE: To investigate the effect of biliopancreatic diversion (BPD) surgery on β-cell function in grade I and II obese patients with type 2 diabetes using oral and intravenous glucose loads. RESEARCH DESIGN AND METHODS: Sixty-eight women were divided into the following three groups: 19 lean-cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Junqueira Vasques, Ana Carolina, Pareja, José Carlos, de Oliveira, Maria da Saude, Satake Novaes, Fernanda, Miranda de Oliveira Lima, Marcelo, Chaim, Élinton A., Piccinini, Francesca, Dalla Man, Chiara, Cobelli, Claudio, Geloneze, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836124/
https://www.ncbi.nlm.nih.gov/pubmed/24135388
http://dx.doi.org/10.2337/dc13-0530
_version_ 1782292271563014144
author Junqueira Vasques, Ana Carolina
Pareja, José Carlos
de Oliveira, Maria da Saude
Satake Novaes, Fernanda
Miranda de Oliveira Lima, Marcelo
Chaim, Élinton A.
Piccinini, Francesca
Dalla Man, Chiara
Cobelli, Claudio
Geloneze, Bruno
author_facet Junqueira Vasques, Ana Carolina
Pareja, José Carlos
de Oliveira, Maria da Saude
Satake Novaes, Fernanda
Miranda de Oliveira Lima, Marcelo
Chaim, Élinton A.
Piccinini, Francesca
Dalla Man, Chiara
Cobelli, Claudio
Geloneze, Bruno
author_sort Junqueira Vasques, Ana Carolina
collection PubMed
description OBJECTIVE: To investigate the effect of biliopancreatic diversion (BPD) surgery on β-cell function in grade I and II obese patients with type 2 diabetes using oral and intravenous glucose loads. RESEARCH DESIGN AND METHODS: Sixty-eight women were divided into the following three groups: 19 lean-control (23.0 ± 2.2 kg/m(2)) and 18 obese-control (35.0 ± 4.8 kg/m(2)) subjects with normal glucose tolerance, and 31 obese patients with type 2 diabetes (36.3 ± 3.7 kg/m(2)). Of the 31 diabetic women, 64% underwent BPD (n = 20, BMI: 36.5 ± 3.7 kg/m(2)) and were reassessed 1 month after surgery. Oral glucose tolerance tests and hyperglycemic clamps were performed. Mathematical modeling was used to analyze basal and stimulated β-cell function, insulin sensitivity (IS), hepatic extraction (HE) of insulin, and delay time of β-cell response to a specific plasma glucose concentration. RESULTS: After BPD, restoration of the basal disposition index (P < 0.001) and improvement of the stimulated disposition indices in oral and intravenous glucose stimulation of the β-cell were observed (P < 0.05). In both dynamic tests, there were no changes in the delay time of β-cell response. IS for oral glucose stimulation (IS(oral)) and intravenous clamp glucose stimulation (IS(clamp)) was completely normalized (P < 0.001). IS(oral) and IS(clamp) increased approximately 5.0-fold and 3.5-fold, respectively (P < 0.01). The HE of insulin increased in the basal (P < 0.05) and stimulated states (P < 0.01). CONCLUSIONS: β-Cell function, IS, and HE of insulin improved after BPD, which improved glycemic control.
format Online
Article
Text
id pubmed-3836124
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-38361242014-12-01 β-Cell Function Improvements in Grade I/II Obese Subjects With Type 2 Diabetes 1 Month After Biliopancreatic Diversion: Results from modeling analyses of oral glucose tolerance tests and hyperglycemic clamp studies Junqueira Vasques, Ana Carolina Pareja, José Carlos de Oliveira, Maria da Saude Satake Novaes, Fernanda Miranda de Oliveira Lima, Marcelo Chaim, Élinton A. Piccinini, Francesca Dalla Man, Chiara Cobelli, Claudio Geloneze, Bruno Diabetes Care Original Research OBJECTIVE: To investigate the effect of biliopancreatic diversion (BPD) surgery on β-cell function in grade I and II obese patients with type 2 diabetes using oral and intravenous glucose loads. RESEARCH DESIGN AND METHODS: Sixty-eight women were divided into the following three groups: 19 lean-control (23.0 ± 2.2 kg/m(2)) and 18 obese-control (35.0 ± 4.8 kg/m(2)) subjects with normal glucose tolerance, and 31 obese patients with type 2 diabetes (36.3 ± 3.7 kg/m(2)). Of the 31 diabetic women, 64% underwent BPD (n = 20, BMI: 36.5 ± 3.7 kg/m(2)) and were reassessed 1 month after surgery. Oral glucose tolerance tests and hyperglycemic clamps were performed. Mathematical modeling was used to analyze basal and stimulated β-cell function, insulin sensitivity (IS), hepatic extraction (HE) of insulin, and delay time of β-cell response to a specific plasma glucose concentration. RESULTS: After BPD, restoration of the basal disposition index (P < 0.001) and improvement of the stimulated disposition indices in oral and intravenous glucose stimulation of the β-cell were observed (P < 0.05). In both dynamic tests, there were no changes in the delay time of β-cell response. IS for oral glucose stimulation (IS(oral)) and intravenous clamp glucose stimulation (IS(clamp)) was completely normalized (P < 0.001). IS(oral) and IS(clamp) increased approximately 5.0-fold and 3.5-fold, respectively (P < 0.01). The HE of insulin increased in the basal (P < 0.05) and stimulated states (P < 0.01). CONCLUSIONS: β-Cell function, IS, and HE of insulin improved after BPD, which improved glycemic control. American Diabetes Association 2013-12 2013-11-13 /pmc/articles/PMC3836124/ /pubmed/24135388 http://dx.doi.org/10.2337/dc13-0530 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Original Research
Junqueira Vasques, Ana Carolina
Pareja, José Carlos
de Oliveira, Maria da Saude
Satake Novaes, Fernanda
Miranda de Oliveira Lima, Marcelo
Chaim, Élinton A.
Piccinini, Francesca
Dalla Man, Chiara
Cobelli, Claudio
Geloneze, Bruno
β-Cell Function Improvements in Grade I/II Obese Subjects With Type 2 Diabetes 1 Month After Biliopancreatic Diversion: Results from modeling analyses of oral glucose tolerance tests and hyperglycemic clamp studies
title β-Cell Function Improvements in Grade I/II Obese Subjects With Type 2 Diabetes 1 Month After Biliopancreatic Diversion: Results from modeling analyses of oral glucose tolerance tests and hyperglycemic clamp studies
title_full β-Cell Function Improvements in Grade I/II Obese Subjects With Type 2 Diabetes 1 Month After Biliopancreatic Diversion: Results from modeling analyses of oral glucose tolerance tests and hyperglycemic clamp studies
title_fullStr β-Cell Function Improvements in Grade I/II Obese Subjects With Type 2 Diabetes 1 Month After Biliopancreatic Diversion: Results from modeling analyses of oral glucose tolerance tests and hyperglycemic clamp studies
title_full_unstemmed β-Cell Function Improvements in Grade I/II Obese Subjects With Type 2 Diabetes 1 Month After Biliopancreatic Diversion: Results from modeling analyses of oral glucose tolerance tests and hyperglycemic clamp studies
title_short β-Cell Function Improvements in Grade I/II Obese Subjects With Type 2 Diabetes 1 Month After Biliopancreatic Diversion: Results from modeling analyses of oral glucose tolerance tests and hyperglycemic clamp studies
title_sort β-cell function improvements in grade i/ii obese subjects with type 2 diabetes 1 month after biliopancreatic diversion: results from modeling analyses of oral glucose tolerance tests and hyperglycemic clamp studies
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836124/
https://www.ncbi.nlm.nih.gov/pubmed/24135388
http://dx.doi.org/10.2337/dc13-0530
work_keys_str_mv AT junqueiravasquesanacarolina bcellfunctionimprovementsingradeiiiobesesubjectswithtype2diabetes1monthafterbiliopancreaticdiversionresultsfrommodelinganalysesoforalglucosetolerancetestsandhyperglycemicclampstudies
AT parejajosecarlos bcellfunctionimprovementsingradeiiiobesesubjectswithtype2diabetes1monthafterbiliopancreaticdiversionresultsfrommodelinganalysesoforalglucosetolerancetestsandhyperglycemicclampstudies
AT deoliveiramariadasaude bcellfunctionimprovementsingradeiiiobesesubjectswithtype2diabetes1monthafterbiliopancreaticdiversionresultsfrommodelinganalysesoforalglucosetolerancetestsandhyperglycemicclampstudies
AT satakenovaesfernanda bcellfunctionimprovementsingradeiiiobesesubjectswithtype2diabetes1monthafterbiliopancreaticdiversionresultsfrommodelinganalysesoforalglucosetolerancetestsandhyperglycemicclampstudies
AT mirandadeoliveiralimamarcelo bcellfunctionimprovementsingradeiiiobesesubjectswithtype2diabetes1monthafterbiliopancreaticdiversionresultsfrommodelinganalysesoforalglucosetolerancetestsandhyperglycemicclampstudies
AT chaimelintona bcellfunctionimprovementsingradeiiiobesesubjectswithtype2diabetes1monthafterbiliopancreaticdiversionresultsfrommodelinganalysesoforalglucosetolerancetestsandhyperglycemicclampstudies
AT piccininifrancesca bcellfunctionimprovementsingradeiiiobesesubjectswithtype2diabetes1monthafterbiliopancreaticdiversionresultsfrommodelinganalysesoforalglucosetolerancetestsandhyperglycemicclampstudies
AT dallamanchiara bcellfunctionimprovementsingradeiiiobesesubjectswithtype2diabetes1monthafterbiliopancreaticdiversionresultsfrommodelinganalysesoforalglucosetolerancetestsandhyperglycemicclampstudies
AT cobelliclaudio bcellfunctionimprovementsingradeiiiobesesubjectswithtype2diabetes1monthafterbiliopancreaticdiversionresultsfrommodelinganalysesoforalglucosetolerancetestsandhyperglycemicclampstudies
AT gelonezebruno bcellfunctionimprovementsingradeiiiobesesubjectswithtype2diabetes1monthafterbiliopancreaticdiversionresultsfrommodelinganalysesoforalglucosetolerancetestsandhyperglycemicclampstudies